Concepts (58)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Leukemoid Reaction | 1 | 2020 | 4 | 0.660 |
Why?
|
| Twins, Monozygotic | 1 | 2020 | 70 | 0.640 |
Why?
|
| Diseases in Twins | 1 | 2020 | 55 | 0.640 |
Why?
|
| Down Syndrome | 1 | 2020 | 46 | 0.620 |
Why?
|
| Cognition Disorders | 2 | 2012 | 217 | 0.400 |
Why?
|
| Exploratory Behavior | 1 | 2012 | 37 | 0.370 |
Why?
|
| Estrogens | 1 | 2012 | 116 | 0.350 |
Why?
|
| Estradiol | 1 | 2012 | 257 | 0.340 |
Why?
|
| Receptors, Dopamine | 1 | 2010 | 16 | 0.320 |
Why?
|
| Neurotransmitter Agents | 1 | 2010 | 42 | 0.320 |
Why?
|
| Schizophrenia | 2 | 2010 | 263 | 0.290 |
Why?
|
| Antipsychotic Agents | 1 | 2010 | 301 | 0.260 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2010 | 87 | 0.160 |
Why?
|
| Potassium | 1 | 2019 | 100 | 0.150 |
Why?
|
| Infant, Newborn | 1 | 2020 | 1363 | 0.120 |
Why?
|
| Prognosis | 1 | 2020 | 1744 | 0.120 |
Why?
|
| Phencyclidine | 2 | 2012 | 3 | 0.120 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2012 | 618 | 0.100 |
Why?
|
| Hallucinogens | 1 | 2012 | 14 | 0.090 |
Why?
|
| Ovariectomy | 1 | 2012 | 103 | 0.090 |
Why?
|
| Hospitalization | 1 | 2019 | 1361 | 0.090 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 215 | 0.090 |
Why?
|
| Rats | 2 | 2012 | 1982 | 0.090 |
Why?
|
| Heart Failure | 1 | 2019 | 915 | 0.090 |
Why?
|
| Parvalbumins | 1 | 2010 | 10 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2012 | 609 | 0.090 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2010 | 76 | 0.080 |
Why?
|
| Neuropsychological Tests | 1 | 2012 | 393 | 0.080 |
Why?
|
| Receptors, GABA | 1 | 2010 | 12 | 0.080 |
Why?
|
| Receptors, Cholinergic | 1 | 2010 | 20 | 0.080 |
Why?
|
| Motor Activity | 1 | 2012 | 346 | 0.080 |
Why?
|
| Disease Models, Animal | 2 | 2012 | 2197 | 0.070 |
Why?
|
| Female | 3 | 2020 | 32971 | 0.060 |
Why?
|
| Neurons | 1 | 2010 | 923 | 0.060 |
Why?
|
| Models, Biological | 1 | 2010 | 1181 | 0.060 |
Why?
|
| Animals | 3 | 2012 | 20697 | 0.050 |
Why?
|
| Time Factors | 1 | 2012 | 3731 | 0.050 |
Why?
|
| Adult | 1 | 2020 | 16899 | 0.050 |
Why?
|
| Brain | 1 | 2010 | 1556 | 0.050 |
Why?
|
| Humans | 3 | 2020 | 63573 | 0.040 |
Why?
|
| Length of Stay | 1 | 2019 | 810 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2019 | 873 | 0.030 |
Why?
|
| Biomarkers | 1 | 2019 | 1407 | 0.030 |
Why?
|
| Glutamate Decarboxylase | 1 | 2010 | 22 | 0.020 |
Why?
|
| Racemases and Epimerases | 1 | 2010 | 24 | 0.020 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2010 | 37 | 0.020 |
Why?
|
| Ketamine | 1 | 2010 | 38 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2010 | 612 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 5481 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 895 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2019 | 5668 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2019 | 6643 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2010 | 2110 | 0.010 |
Why?
|
| Male | 2 | 2019 | 29956 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2010 | 3398 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 14477 | 0.010 |
Why?
|
| Middle Aged | 1 | 2019 | 17677 | 0.010 |
Why?
|
| Mice | 1 | 2010 | 10849 | 0.010 |
Why?
|